newsfilter
← Latest News
GlobeNewswire·

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates